Hallucinogen abuse with intoxication, uncomplicated
ICD-10 F16.120 is a billable code used to indicate a diagnosis of hallucinogen abuse with intoxication, uncomplicated.
Hallucinogen abuse with intoxication, uncomplicated (F16.120) refers to the use of hallucinogenic substances that leads to a state of intoxication without the presence of any complicating factors such as withdrawal symptoms or co-occurring mental health disorders. Hallucinogens, including substances like LSD, psilocybin mushrooms, and mescaline, can cause significant alterations in perception, mood, and cognitive processes. Patients may experience visual or auditory hallucinations, altered sense of time, and profound changes in thought patterns. The uncomplicated nature of this diagnosis indicates that the individual is not experiencing severe physiological or psychological complications that often accompany substance use disorders. Treatment typically involves supportive care, monitoring, and counseling, focusing on harm reduction and education about the risks associated with hallucinogen use. It is crucial for healthcare providers to assess the patient's history of substance use, mental health status, and any potential for future substance abuse to provide appropriate interventions.
Detailed patient history, substance use patterns, and treatment plans.
Patients presenting with acute intoxication, requiring monitoring and supportive care.
Consideration of co-occurring mental health disorders and the need for integrated treatment approaches.
Comprehensive mental health evaluations and treatment progress notes.
Patients with a history of hallucinogen use presenting with psychological symptoms.
Assessment of underlying mental health conditions that may influence treatment.
Used for initial assessment of patients presenting with hallucinogen intoxication.
Comprehensive assessment notes detailing the patient's mental state and substance use history.
Addiction specialists should focus on substance use patterns and potential for future abuse.
F16.120 is used for uncomplicated hallucinogen intoxication, while F16.121 is for cases where withdrawal symptoms are present.
